NinaDelaneyWagner-JohnstonMD

Oncology • Baltimore, MD

Assistant Professor, Internal Medicine, Washington University School of Medicine

Join to view full profile

Dr. Wagner-Johnston is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Wagner-Johnston's full profile

Already have an account?

Office
401 N. Broadway
Baltimore, MD 21231
Is this information wrong?

Education & Training

Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 2005 - 2008
University of ChicagoResidency, Internal Medicine, 2003 - 2005
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 2003

Certifications & Licensure

MD State Medical License 2005 - 2025
DC State Medical License 2022 - 2024
MO State Medical License 2008 - 2016
IL State Medical License 2003 - 2006

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2012

Clinical Trials

Study of Blood and Tissue Samples From Patients With Aggressive Non-Hodgkin B-Cell Lymphoma or Hodgkin Lymphoma Start of enrollment: 2009 Aug 01
Completed
Evaluate the Efficacy of Armodafinil for Patients With B-cell Lymphoma and Severe Fatigue Start of enrollment: 2010 Mar 01
Withdrawn
Not Applicable
Combination Chemotherapy With or Without Autologous Stem Cell Transplant in Treating Patients With Central Nervous System B-Cell Lymphoma Start of enrollment: 2012 Sep 01
Active, not recruiting
Phase 2
Phase I/II Study of Abraxane in Recurrent and Refractory Lymphoma Start of enrollment: 2012 Jul 01
Terminated
Phase 1
Study of Rituximab and Brentuximab Vedotin for Relapsed Classical Hodgkin Lymphoma Start of enrollment: 2014 Jun 01
Terminated
Phase 1
Efficacy and Safety of Idelalisib in Combination With Rituximab in Patients With Previously Untreated Chronic Lymphocytic Leukemia With 17p Deletion Start of enrollment: 2014 Aug 06
Terminated
Phase 2
Brentuximab Vedotin and Lenalidomide for Relapsed or Refractory Diffuse Large B-cell Lymphoma Start of enrollment: 2014 Sep 18
Completed
Phase 1
Falls Risk Questionnaire in Older Adults With Cancer Start of enrollment: 2014 Aug 01
Completed
Perspectives on Bone Marrow Donors Who Donate for Their Parent Start of enrollment: 2016 Dec 06
Completed
Non-Invasive Neurosensory Testing For Chemotherapy-Induced Peripheral Neuropathy Start of enrollment: 2017 Nov 29
Completed
A Comparison of Three Chemotherapy Regimens for the Treatment of Patients With Newly Diagnosed Mantle Cell Lymphoma Start of enrollment: 2019 Dec 13
Active, not recruiting
Phase 2
HMPL-760 Safety and Tolerability Study in Patients With Previously Treated CLL/SLL or NHL Start of enrollment: 2022 Feb 15
Withdrawn
Phase 1
Roles: Contact, Principal Investigator
Join now to see all

Publications & Presentations

PubMed

Myeloablative Vs. Non-Myeloablative Consolidation for Primary Central Nervous System Lymphoma: Results of Alliance 51101.
Tracy T Batchelor, Sharmila Giri, Amy S Ruppert, Susan Geyer, Scott E Smith, Jonathan W Friedberg, Brad S Kahl, Nancy L Bartlett, Eric D Hsi, John P Leonard, James Lou...> ;Blood Advances. 2024 Apr 10
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 2.2024.
Fakhri, B., William G Wierda, Jennifer Brown, Jeremy S Abramson, Farrukh Awan, Syed F Bilgrami, Greg Bociek, Danielle Brander, Matthew Cortese, Larry Cripe, Randall S ...> ;Journal of the National Comprehensive Cancer Network. 2024 Apr 1
TRBC1-targeting antibody-drug conjugates for the treatment of T cell cancers.
Tushar D Nichakawade, Jiaxin Ge, Brian J Mog, Bum Seok Lee, Alexander H Pearlman, Michael S Hwang, Sarah R DiNapoli, Nicolas Wyhs, Nikita Marcou, Stephanie Glavaris, M...> ;Nature. 2024 Apr 1
Outcomes of patients with blastoid and pleomorphic variant mantle cell lymphoma.
Gerson, J., Handorf, E., Villa, D., Gerrie, A., Chapani, P., Li, S., Medeiros, L., Wang, M., Cohen, J., Churnetski, M., Hill, B., Sawalha, Y., Hernandez-Ilizaliturri, ...> ;Blood Advances. 2023 Dec 26
Overall survival of patients with cHL who progress after autologous stem cell transplant: results in the novel agent era.
Sanjal H Desai, Michael A Spinner, Andrew M Evens, Alice Sykorova, Veronika Bachanova, Gaurav Goyal, Brad Kahl, Kathleen Dorritie, Jacues Azzi, Vaishalee P Kenkre, Che...> ;Blood Advances. 2023 Dec 12
A phase II study of interrupted and continuous dose lenalidomide in relapsed/refractory Hodgkin lymphoma.
Todd A Fehniger, Marcus P Watkins, Nkiruka Ezenwajiaku, Fei Wan, David D Hurd, Amanda F Cashen, Kristie A Blum, Andre Goy, Timothy S Fenske, Nina D Wagner-Johnston, Ke...> ;Haematologica. 2024 Mar 1
2 citations
Outpatient CD19-directed CAR T-cell therapy is feasible in patients of all ages.
Andrew Ly, Khaled Sanber, Hua-Ling Tsai, Angela Ondo, Kathy Mooney, Audra Shedeck, Julie Baker, Philip Hollingsworth Imus, Nina Wagner-Johnston, Tania Jain> ;British Journal of Haematology. 2023 Nov 1
Outpatient CD28-costimulated CAR T-cells for B-cell malignancies with CNS involvement.
Khaled Sanber, Andrew Ly, Angela Ondo, Kathy Mooney, Julie Baker, Audra Shedeck, Nina Wagner-Johnston, Tania Jain> ;American Journal of Hematology. 2023 Nov 1
9 citations
Alternative donor BMT with posttransplant cyclophosphamide as initial therapy for acquired severe aplastic anemia.
Amy E DeZern, Marianna Zahurak, Heather J Symons, Kenneth R Cooke, Carol Ann Huff, Tania Jain, Lode J Swinnen, Philip H Imus, Nina D Wagner-Johnston, Richard F Ambinde...> ;Blood. 2023 Jun 22
1 citations
Allogeneic Blood or Marrow Transplantation with High-Dose Post-Transplantation Cyclophosphamide for Acute Lymphoblastic Leukemia in Patients Age ≥55 Years.
Jonathan A Webster, Madison Reed, Hua-Ling Tsai, Alexander Ambinder, Tania Jain, Amy E Dezern, Mark J Levis, Margaret M Showel, Gabrielle T Prince, Christopher S Houri...> ;Transplantation and Cellular Therapy. 2023 Mar 1
4 citations
Positron Emission Tomography-Adapted Therapy in Bulky Stage I/II Classic Hodgkin Lymphoma: CALGB 50801 (Alliance).
Ann S LaCasce, Travis Dockter, Amy S Ruppert, Lale Kostakoglu, Heiko Schöder, Eric Hsi, Jeffrey Bogart, Bruce Cheson, Nina Wagner-Johnston, Jeremy Abramson, Kristie Bl...> ;Journal of Clinical Oncology. 2023 Feb 10
7 citations
Outcomes of patients with limited-stage plasmablastic lymphoma: A multi-institutional retrospective study.
Brian T Hess, Anshu Giri, Yeonhee Park, Krina K Patel, Brian K Link, Grzegorz S Nowakowski, Seth M Maliske, Sonia Fortin, Julio C Chavez, Hayder Saeed, Brian T Hill, A...> ;American Journal of Hematology. 2023 Feb 1
1 citations
Allogeneic Blood or Marrow Transplantation with Post-Transplantation Cyclophosphamide for Peripheral T Cell Lymphoma: The Importance of Graft Source.
Cole H Sterling, Michael S Hughes, Hua-Ling Tsai, Kathryn Yarkony, Ephraim J Fuchs, Lode J Swinnen, Suman Paul, Javier Bolaños-Meade, Leo Luznik, Philip H Imus, Syed A...> ;Transplantation and Cellular Therapy. 2023 Apr 1
2 citations
Mismatched donor transplantation with post-transplantation cyclophosphamide for advanced cutaneous T-cell lymphoma: a single-center retrospective study.
Michael S Hughes, Cole H Sterling, Ravi Varadhan, Richard F Ambinder, Richard J Jones, Ronald J Sweren, Sima Rozati, Javier Bolaños-Meade, Leo Luznik, Philip H Imus, S...> ;Leukemia & Lymphoma. 2022 Dec 1
6 citations
Hyperinflammatory syndrome resembling haemophagocytic lymphohistiocytosis following axicabtagene ciloleucel and brexucabtagene autoleucel.
Timothy J Porter, Ana Lazarevic, Jamie E Ziggas, Ephraim Fuchs, Kiryoung Kim, Helen Byrnes, Leo Luznik, Javier Bolaños-Meade, Syed Abbas Ali, Nirali N Shah, Nina Wagne...> ;British Journal of Haematology. 2022 Dec 1
2 citations
Long-term safety for patients with tisagenlecleucel-treated relapsed/refractory diffuse large B-cell lymphoma.
Ulrich Jaeger, Constantine S Tam, Peter Borchmann, Joseph P McGuirk, Marianne Johansen, Edmund K Waller, Samantha Jaglowski, Charalambos Andreadis, Stephen R Foley, Ja...> ;Blood Advances. 2022 Aug 23
53 citations
Lisocabtagene maraleucel as second-line therapy in adults with relapsed or refractory large B-cell lymphoma who were not intended for haematopoietic stem cell transpla...
Alison Sehgal, Daanish Hoda, Peter A Riedell, Nilanjan Ghosh, Mehdi Hamadani, Gerhard C Hildebrandt, John E Godwin, Patrick M Reagan, Nina Wagner-Johnston, James Essel...> ;The Lancet. Oncology. 2022 Aug 1
29 citations
NCCN Guidelines® Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 3.2022.
William G Wierda, Jennifer Brown, Jeremy S Abramson, Farrukh Awan, Syed F Bilgrami, Greg Bociek, Danielle Brander, Asher A Chanan-Khan, Steve E Coutre, Randall S Davis...> ;Journal of the National Comprehensive Cancer Network. 2022 Jun 1
11 citations
Post-Transplantation Cyclophosphamide-Based Graft- versus-Host Disease Prophylaxis with Nonmyeloablative Conditioning for Blood or Marrow Transplantation for Myelofibr...
Tania Jain, Hua-Ling Tsai, Amy E DeZern, Lukasz P Gondek, Hany Elmariah, Javier Bolaños-Meade, Leonido Luznik, Ephraim Fuchs, Richard Ambinder, Douglas E Gladstone, Ph...> ;Transplantation and Cellular Therapy. 2022 May 1
14 citations
Pembrolizumab plus dinaciclib in patients with hematologic malignancies: the phase 1b KEYNOTE-155 study.
Gregory, G., Kumar, S., Wang, D., Mahadevan, D., Walker, P., Wagner-Johnston, N., Escobar, C., Bannerji, R., Bhutani, D., Chang, J., Hernandez-Ilizaliturri, F., Klein,...> ;Blood Advances. 2022 Feb 22
2 citations
Clinical utility of chromosomal microarray in establishing clonality and high risk features in patients with Richter transformation.
Brian T. Hess, James Kalmuk, Iya Znoyko, Cynthia A. Schandl, Nina D. Wagner-Johnston, Sandra Mazzoni, Lindsey Hendrickson, Zane Chiad, Irl Brian Greenwell, Daynna J. W...> ;Cancer Genetics. 2022 Jan 1
13 citations
Phase I/Dose Expansion Trial of Brentuximab vedotin/Lenalidomide in Relapsed or Refractory Diffuse Large B-cell Lymphoma.
Jeffrey P. Ward, Melissa M. Berrien-Elliott, Felicia Gomez, Jingqin Luo, Michelle Becker-Hapak, Amanda F. Cashen, Nina D. Wagner-Johnston, Kami J. Maddocks, Matthew Mo...> ;Blood. 2021 Nov 15
Correction to: Cisplatin-associated neuropathy characteristics compared with those associated with other neurotoxic chemotherapy agents (Alliance A151724).
Costantine Albany, Travis Dockter, Eric Wolfe, Jennifer Le-Rademacher, Nina Wagner-Johnston, Lawrence Einhorn, Jacqueline M Lafky, Ellen Smith, Deirdre Pachman, Nathan...> ;Supportive Care in Cancer. 2021 Nov 1
4 citations
Nonmyeloablative Allogeneic Transplantation With Post-Transplant Cyclophosphamide for Acute Myeloid Leukemia With IDH Mutations: A Single Center Experience.
Alexander J. Ambinder, Matthew D. Smith, Hua-Ling Tsai, Ravi Varadhan, Amy E. DeZern, William Dalton, Christian B. Gocke, Jonathan Webster, Lukasz P. Gondek, Ivana Goj...> ;Clinical Lymphoma, Myeloma & Leukemia. 2021 Oct 9
170 citations
Long-term clinical outcomes of tisagenlecleucel in patients with relapsed or refractory aggressive B-cell lymphomas (JULIET): a multicentre, open-label, single-arm, ph...
Stephen J. Schuster, Constantine S. Tam, Peter Borchmann, Nina Worel, Joseph P. McGuirk, Harald Holte, Edmund K. Waller, Samantha Jaglowski, Michael R. Bishop, Lloyd E...> ;The Lancet. Oncology. 2021 Oct 1
Join now to see all

Abstracts/Posters

A Phase IB Study of Blinatumomab (blina) in Patients with B Cell Acute Lymphoblastic Leukemia (ALL) and B-Cell Non-Hodgkin Lymphoma (NHL) As Post-Allogeneic Blood or M...
Nina D. Wagner-Johnston, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Impact of Tisagenlecleucel Chimeric Antigen Receptor (CAR)-T Cell Therapy Product Attributes on Clinical Outcomes in Adults with Relapsed or Refractory Diffuse Large B...
Nina D. Wagner-Johnston, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Correlation of Bridging and Lymphodepleting Chemotherapy with Clinical Outcomes in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma Treated with Tisagen...
Nina D. Wagner-Johnston, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Correlative Analyses of Patient and Clinical Characteristics Associated with Efficacy in Tisagenlecleucel-Treated Relapsed/Refractory Diffuse Large B-Cell Lymphoma Pat...
Nina D. Wagner-Johnston, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Allogenic Stem Cell Transplantation for Secondary CNS Lymphoma: A Retrospective Review of 21 Patients
Nina D. Wagner-Johnston, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Join now to see all

Lectures

Long-Term Follow-up of Idelalisib Monotherapy in Patients with Double-Refractory Marginal Zone Lymphoma or Lymphoplasmacytic Lymphoma/ Waldenstrom's Macroglobulinemia
61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
Checkpoint Blockade Therapy May Sensitize Hodgkin Lymphoma to Subsequent Therapy
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Checkpoint Blockade Therapy May Sensitize Aggressive and Indolent Non-Hodgkin Lymphoma to Subsequent Therapy
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Sustained Disease Control for Adult Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma: An Updated Analysis of Juliet, a Global Pivotal Phase 2 Trial o...
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Making Strides in the Treatment of B-Cell Malignancies: Keeping Up With New Data and Practice Recommendations
60th American Society of Hematology Annual Meeting - 11/30/2018
Join now to see all